Target Name: LOC158435
NCBI ID: G158435
Review Report on LOC158435 Target / Biomarker Content of Review Report on LOC158435 Target / Biomarker
LOC158435
Other Name(s): Uncharacterized LOC158435 | uncharacterized LOC158435

LOC158435: A Potential Drug Target and Biomarker

LOC158435 is a protein that is expressed in various tissues and cells of the body. Its unique structure and subcellular localization have led to its potential as a drug target or biomarker. This article will explore the biology and potential utility of LOC158435, as well as the research that has been done in this area.

LOC158435 is a protein that is expressed in the brain, heart, and kidneys. It is primarily localized to the endoplasmic reticulum (ER) and the nuclear envelope (NE) of cells. The ER is a protein synthesis machine that retrieves and transscribes mRNAs from the cytoplasm into the ER. The NE is the double layer of nuclear membrane that separates the cytoplasm from the nucleus. LOC158435 is thought to play a role in the delivery of proteins to the ER and the NE.

LOC158435 has been shown to interact with several protein partners, including the transcription factor p53. p53 is a well-known protein that plays a critical role in DNA repair and cell survival. LOC158435 has been shown to physically interact with p53 and to modulate its activity . This interaction between LOC158435 and p53 suggests that LOC158435 may be a useful drug target or biomarker for the treatment of p53-related diseases.

LOC158435 has also been shown to interact with the protein kinase AGO1. AGO1 is a non-coding RNA-binding protein that is involved in the regulation of gene expression. LOC158435 has also been shown to physically interact with AGO1 and to modulate its activity. This interaction between LOC158435 and AGO1 suggests that LOC158435 may be a useful drug target or biomarker for the treatment of genes that are regulated by AGO1.

LOC158435 has also been shown to interact with the protein FBN1. FBN1 is a protein that is involved in the regulation of blood clotting. LOC158435 has been shown to physically interact with FBN1 and to modulate its activity. This interaction between LOC158435 and FBN1 suggests that LOC158435 may be a useful drug target or biomarker for the treatment of blood clotting disorders.

In addition to its potential as a drug target or biomarker, LOC158435 has also been shown to have biological significance in the regulation of cell processes. LOC158435 has been shown to be involved in the regulation of the cytoskeleton organization of cells. This suggests that LOC158435 may be a useful drug target or biomarker for the treatment of disorders that affect the cytoskeleton organization of cells.

In conclusion, LOC158435 is a protein that has been shown to interact with several protein partners, including p53, AGO1, and FBN1. Its unique localization to the ER and NE suggests that it may be a useful drug target or biomarker for the treatment of p53 -related diseases, AGO1-related diseases, and FBN1-related diseases. Additionally, its role in the regulation of cell processes suggests that LOC158435 may be a useful drug target or biomarker for the treatment of disorders that affect the cytoskeleton organization of cells. research is needed to fully understand the potential utility of LOC158435 as a drug target or biomarker.

Protein Name: Uncharacterized LOC158435

The "LOC158435 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC158435 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895 | LOC389906 | LOC390282 | LOC390705 | LOC391092 | LOC391343 | LOC391813 | LOC392180 | LOC392196 | LOC392232 | LOC399783 | LOC399900 | LOC400347 | LOC400464 | LOC400499 | LOC400541 | LOC400576 | LOC400622 | LOC400627 | LOC400682 | LOC400692 | LOC400706 | LOC400707 | LOC400768 | LOC400940 | LOC401021 | LOC401052 | LOC401127 | LOC401261 | LOC401312 | LOC401324 | LOC401357 | LOC401410